NJ State Employees Deferred Compensation Plan’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,000
Closed -$426K 175
2025
Q3
$426K Hold
1,000
0.05% 313
2025
Q2
$383K Hold
1,000
0.05% 318
2025
Q1
$346K Hold
1,000
0.04% 336
2024
Q4
$300K Hold
1,000
0.04% 363
2024
Q3
$406K Hold
1,000
0.05% 337
2024
Q2
$321K Hold
1,000
0.04% 359
2024
Q1
$334K Hold
1,000
0.04% 358
2023
Q4
$271K Hold
1,000
0.04% 387
2023
Q3
$246K Hold
1,000
0.04% 386
2023
Q2
$303K Hold
1,000
0.04% 370
2023
Q1
$264K Hold
1,000
0.04% 396
2022
Q4
$240K Buy
+1,000
New +$224K 0.04% 398
2022
Q2
Sell
-1,000
Closed -$251K 485
2022
Q1
$251K Hold
1,000
0.03% 426
2021
Q4
$257K Hold
1,000
0.03% 433
2021
Q3
$243K Hold
1,000
0.03% 441
2021
Q2
$207K Buy
+1,000
New +$204K 0.03% 481

Other funds holding HCA

NJ State Employees Deferred Compensation Plan's HCA Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 1,000 shares — an estimated $426K sold.

NJ State Employees Deferred Compensation Plan first reported a position in HCA in Q2 2021 and held it in 16 quarters. The position peaked at $426K in Q3 2025. 1,398 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

  • NJ State Employees Deferred Compensation Plan reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 1,000 HCA Healthcare shares in Q4 2025, an estimated $426K.
  • NJ State Employees Deferred Compensation Plan first reported a position in HCA Healthcare in Q2 2021 and held it in 16 quarters.
  • NJ State Employees Deferred Compensation Plan's HCA Healthcare position peaked at $426K in Q3 2025.
  • 1,398 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.